References
- Gery I, Mochizuki M, Nussenblatt R B. Retinal specific antigens and immunopathogenic processes they provoke. Progress in Retinal Research, N Osborne, J Chader. Pergamon Press, Oxford and New York 1986; Vol 5: 75–109
- Streilein J W. Immune regulati'on and the eye: a dangerous compromise. FASEB J 1987; 1: 199–208
- Nussenblatt R B, Caspi R R, Mahdi R, Chan C C, Roberge F, Lider O, Weiner H L. Inhibition of S-antigen induced experimental autoimmune uveoretinitis by oral induction of tolerance with S-antigen. J Immunol 1990; 144: 1689–1695
- Barker C F, Billingham R E. Immunologically privileged sites. Adv Immunol 1977; 25: 1–54
- Das N D, Ulshafer R F, Zam Z S, Leverenz V R, Shichi H. Radioimmunocytochemical localization of retinal S-antigen with monoclonal antibodies. J Histochem Cytochem 1984; 32: 834–838
- Smith P K, Krohn R I, Hermanson R I, Malia A K, Gamer F H, Provenzano M D, Fujimoto E K, Goeke N W, Olson B J, Klenk D C. Measurement of protein using bicinchoninic acid. Anal Biochem 1985; 150: 76–85
- Tanouchi Y, Shichi H. Immunosuppressive effects of polynactins (tetranactin. trinactin and dinactin) on experimental autoimmune uveoretinitis in rats. Jpn J Ophthalmol 1987; 31: 218–229
- Tuyen V V, Faure J P, Thillaye B, DeKozak Y, Fortier B. Anti-body determination by ELISA in rats with retinal S-antigen-induced uveoretinitis. Curr Eye Res 1982/1983; 2: 7–12
- Mizuno K, Clark A F, Streilein J W. Ocular injection of retinal S antigen: Suppression of autoimmune uveitis. Invest Ophthalmol Vis Sci 1989; 30: 772–774
- Waldrep J C, Kaplan H J. Cyclophosphamide-sensitive contras-uppression in TNP-anterior chamber associated immune deviation (TNP-ACAID). J Immunol 1983; 131: 2746–2750
- Waldrep J C, Kaplan H J. Anterior chamber-associated immune deviation induced by TNP-splenocytes (TNP-ACAID). II. Suppressor T-cell networks. Invest Ophthalmol Vis Sci 1983; 24: 1339–1345
- Wilbanks G A, Streilein J W. Studies on the induction of anterior chamber-associated immune deviation (ACAID). 1. Evidence that an antigen-specific ACAID-inducing, cell-associated signal exists in the peripheral blood. J. Immunol 1991; 146: 2610–2617
- Miller A, Hafler D A, Weiner H L. Tolerance and suppressor mechanisms in experimental autoimmune encephalomyelitis: implications for immunotherapy of human autoimmune diseases. FASEE J 1991; 5: 2560–2566
- Whitacre C C, Gienapp I E, Orosz C G, Bitar D M. Oral tolerance in experimental autoimmune encephalomyelitis. III. Evidence for clonal anergy. J Immunol 1991; 147: 2155–2163
- Wilbanks G A, Mammolenti M, Streilein J W. Studies on the induction OF anterior chamber-associated immune deviation (ACAID). 11. Eye-derived cells participate in generating blood-borne signals that induce ACAID. J Immunol 1991; 146: 3018–3024
- Ferguson T A, Hayashi J D, Kaplan H J. The immune responses and the eye. III, Anterior chamber-associated immune deviation can be adoptively transferred by serum. J Immunol 1989; 143: 821–826
- Streilein J W, Niederkorn J Y. Induction of anterior chamber-associated immune deviation requires an intact functional spleen. J Exp Med 1981; 153: 1058–1067
- Kuruvilla A P, Shah R, Hochwald G M, Liggitt H D, Palladino M A, Thorbecke G J. Protective effect of TGF β1 on experimental autoimmune diseases in mice. Proc Natl Acad Sci USA 1991; 88: 2918–2921
- Johns L D, Flanders K C, Ranges G E, Sriram S. Successful treatment of experimental allergic encephalomyelitis with transforming growth factor-β1. J Immunol 1991; 147: 1792–1796